55.00
+0.50
+(0.92%)
At close: January 31 at 5:25:14 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
308,124.00
259,468.00
186,587.00
204,206.00
Total Liabilities Net Minority Interest
58,841.00
29,002.00
38,582.00
19,352.00
Total Equity Gross Minority Interest
249,283.00
230,466.00
148,005.00
184,854.00
Total Capitalization
297,657.00
240,234.00
152,879.00
189,489.00
Common Stock Equity
249,283.00
230,466.00
148,005.00
184,854.00
Capital Lease Obligations
2,955.00
880.00
934.00
1,312.00
Net Tangible Assets
248,738.00
229,921.00
147,460.00
184,309.00
Working Capital
281,016.00
223,967.00
136,641.00
188,301.00
Invested Capital
297,657.00
240,234.00
152,879.00
189,489.00
Tangible Book Value
248,738.00
229,921.00
147,460.00
184,309.00
Total Debt
51,329.00
10,648.00
5,808.00
5,947.00
Share Issued
667,659.63
631,338.25
480,082.97
488,304.45
Ordinary Shares Number
643,536.09
606,301.05
480,082.97
463,304.45
Treasury Shares Number
24,123.54
25,037.19
--
25,000.00
12/31/2020 - 9/24/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
12X1.F Anavex Life Sciences Corp.
9.11
-0.87%
0QF.DE Moderna, Inc.
39.44
-2.17%
22UA.DE BioNTech SE
118.40
-0.17%
NAMS NewAmsterdam Pharma Company N.V.
22.29
+2.39%
AVXL Anavex Life Sciences Corp.
9.27
-3.13%
AXSM Axsome Therapeutics, Inc.
106.46
-2.20%
CRSP CRISPR Therapeutics AG
41.59
-1.07%
VRTX Vertex Pharmaceuticals Incorporated
461.68
+5.31%